Gray Nancy Ryan bought LGND

November 7, 2025 · Form 4 insider transaction

Gray Nancy Ryan bought 3,556 shares of Ligand Pharmaceuticals Incorporated at $66.19 per share, a transaction worth $235.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
3,556
Price
$66.19
Total value
$235.4K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after11,650
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR